Literature DB >> 29530925

Changes in the Neuronal Control of the Urinary Bladder in a Model of Radiation Cystitis.

Daniel Giglio1, Lucie Podmolíková2, Gunnar Tobin2.   

Abstract

Currently, we have assessed the neuronal control of the urinary bladder in radiation cystitis and whether interstitial cells contribute to the condition. Fourteen days after bladder irradiation (20 Gy), rats were sedated and the urinary bladder was cut into two sagittal halves where electrical field stimulation (EFS; 5-20 Hz) was applied on the pelvic nerve afferents or stretch (80 mN) on one-half of the bladder, while contractions were registered on the contralateral half of the bladder in the absence and presence of increasing doses of imatinib (1-10 mg/kg; inhibitor of c-kit-positive interstitial cells), atropine (1 mg/kg; to block muscarinic M3 receptors), or pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (2 mg/kg; P2X1 purinoceptor antagonist). Urinary bladders were also excised for organ bath experiments, Western blot, quantitative polymerase chain reaction, and immunohistochemistry. In vivo, EFS contractions were enhanced after irradiation, and imatinib (1-10 mg/mg) inhibited contractions by EFS and stretched dose-dependently in controls but not in irradiated bladders. In the irradiated bladder in vitro, atropine resistance was increased and imatinib (100 µM) inhibited contractions by EFS and agonists (ATP, methacholine) in irradiated bladders and controls. The urinary bladder expressions of P2X1 purinoceptors, muscarinic M3 receptor, choline acetyltransferase, c-kit, and the agonist of c-kit, stem cell factor, were not changed by irradiation. In conclusion, bladder irradiation affects several levels of neuronal control of the urinary bladder. Interstitial cells may contribute to some of the symptoms associated with radiation cystitis.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2018        PMID: 29530925     DOI: 10.1124/jpet.117.246371

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Imatinib Mesylate Reduces Voiding Frequency in Female Mice With Acute Cyclophosphamide-Induced Cystitis.

Authors:  Megan E Perkins; Beatrice M Girard; Susan E Campbell; Margaret A Vizzard
Journal:  Front Syst Neurosci       Date:  2022-05-13

Review 2.  Can radiation-induced lower urinary tract disease be ameliorated in patients treated for pelvic organ cancer: ICI-RS 2019?

Authors:  Ruud Bosch; Karen McCloskey; Amit Bahl; Salvador Arlandis; Jeremy Ockrim; Jeffrey Weiss; Tamsin Greenwell
Journal:  Neurourol Urodyn       Date:  2020-07       Impact factor: 2.696

Review 3.  Understanding Molecular Mechanisms and Identifying Key Processes in Chronic Radiation Cystitis.

Authors:  Clément Brossard; Anne-Charlotte Lefranc; Jean-Marc Simon; Marc Benderitter; Fabien Milliat; Alain Chapel
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

4.  Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis.

Authors:  Megan Perkins; Beatrice M Girard; Susan E Campbell; Grant W Hennig; Margaret A Vizzard
Journal:  Front Syst Neurosci       Date:  2022-04-22

5.  Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer.

Authors:  Ling He; Zhenyu Wang; Jianhui Chen; Ling Chen; Peijuan Chen; Wenzhi Cai
Journal:  J Healthc Eng       Date:  2022-04-15       Impact factor: 3.822

6.  Purinergic signalling in the urinary bladder - When function becomes dysfunction.

Authors:  Christopher H Fry; Karen D McCloskey
Journal:  Auton Neurosci       Date:  2021-07-17       Impact factor: 2.355

7.  Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): A Randomised Controlled Study.

Authors:  Juan Palou Redorta; Francesco Sanguedolce; Gemma Sancho Pardo; Martin Romancik; Gianni Vittori; Andrea Minervini; Fabrizio Di Maida; Richard Lunik; Renzo Colombo; Vincenzo Serretta; Bülent Çetinel; Vittorio Bini; Davide Corradengo; Massimo Lazzeri
Journal:  Eur Urol Open Sci       Date:  2021-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.